Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 2
Author(s): Gustav Akk
Affiliation:
Export Options
About this article
Cite this article as:
Akk Gustav, Meet Our Editorial Board Member, Current Neuropharmacology 2015; 13 (2) . https://dx.doi.org/10.2174/1570159X1302150525143440
DOI https://dx.doi.org/10.2174/1570159X1302150525143440 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance
Combinatorial Chemistry & High Throughput Screening Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Sleep, Depression and Insomnia – A Vicious Circle?
Current Psychiatry Reviews Current Status of Hormone Replacement Therapy in Post Menopausal Women
Current Drug Therapy The Alzheimer Pandemic: Is Paracetamol to Blame?
Inflammation & Allergy - Drug Targets (Discontinued) A Review of Methods and Tools for Database Integration in Biomedicine
Current Bioinformatics The Pharmacological Control of Neuronal Excitability in the Retinal Spreading Depression Model of Migraine
Current Medicinal Chemistry Probiotics as an Adjuvant Therapy in Major Depressive Disorder
Current Neuropharmacology Microwave-Assisted Chemistry of 2(1H)-pyrazinones
Current Organic Chemistry “My Drink is Larger than Yours”? A Literature Review of Self-Defined Drink Sizes and Standard Drinks
Current Drug Abuse Reviews Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
Current Neuropharmacology From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017
CNS & Neurological Disorders - Drug Targets Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials
Current Topics in Medicinal Chemistry Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development
Current Neuropharmacology Complement Activation-Related Pseudoallergy Caused by Amphiphilic Drug Carriers: The Role of Lipoproteins
Current Drug Delivery Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents
Current Drug Delivery